Placing the Bulls-Eye Focus on Quest Diagnostics Incorporated (NYSE:DGX)

Are shares of Quest Diagnostics Incorporated (NYSE:DGX) ready to make a move?  Increased volatility and interest from bargain investors have put the stock on a number of investor’s watchlists of late.  The stock is pricing at $93.04 after moving 0.11% from the opening bell. 

Sometimes the stock market can be very confusing, even for the most seasoned investors. Even when expectations are met as predicted, the market may decide to move otherwise. This can cause uncertainty and second guessing. Keeping up with historical data as well as short-term and long-term trends may be very helpful. Over the past week, Quest Diagnostics Incorporated (NYSE:DGX) shares have performed 1.08%. Pushing back over the last quarter, shares are -11.39%. Looking at stock performance for the past six months, shares are -12.68%. Since the start of the calendar year, shares have performed 1.24%.

Let’s take a quick look at some possible support and resistence levels for the stock. According to a recent spotcheck, company Quest Diagnostics Incorporated (NYSE:DGX) have been seen trading -14.35% away from the 50- day high. On the opposite end, shares have been trading 3.26% away from the 50-day low price. Taking a wider perspective, shares have been recently trading -17.64% off the 52-week high and 10.00% away from the 52-week low.

Of course, there is no easy answer to solving the tough question of how to best approach the stock market, especially when dealing with a turbulent investing climate. There are many different schools of thought when it comes to trading equities. Investors may have to first asses their appetite for risk in order to form a solid platform on which to construct a legitimate strategy.

Does one run with the bulls and roar with the bears? Do they go against the grain and form a contrarian investing plan? The abundance of information with relatively easy access has made the road a bit smoother to walk for novice investors. Making the transition to the next level is where the champions are able to separate themselves from the pretenders.

So, most importantly, where are shares headed from here? In order to get a sense of Wall Street sentiment, we can look to brokerage analyst estimates. On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. Quest Diagnostics Incorporated currently has an average analyst recommendation of 2.80 according to analysts. This is the average number based on the total brokerage firms taken into consideration by Beta Systems Research. The same analysts have a future one-year price target of $99.79 on the shares.